LRMR stock

Analysts review Larimar Therapeutics Inc’s rating

Anna Perez

Larimar Therapeutics Inc’s filing revealed that its Director Flynn James E acquired Company’s shares for reported $30.0 million on Jul ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.